Hydromorphone-induced Neurostimulation in a Yorkshire Swine (Sus scrofa) after Myocardial Infarction Surgery

Opiates play an important role in the control of pain associated with thoracotomy in both people and animals. However, key side effects, including sedation and respiratory depression, could limit the use of opiates in animals that are lethargic due to cardiac disease. In addition, a rare side effect...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Association for Laboratory Animal Science Vol. 58; no. 5; pp. 601 - 605
Main Authors Rodriguez, Inés, Philips, Blythe H, Miedel, Emily L, Bright, Lauren A, LaTourette II, Philip C, Carty, Anthony J, Witschey, Walter R, Gorman, Robert C, Gorman III, Joseph H, Marx, James O
Format Journal Article
LanguageEnglish
Published United States American Association for Laboratory Animal Science 01.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Opiates play an important role in the control of pain associated with thoracotomy in both people and animals. However, key side effects, including sedation and respiratory depression, could limit the use of opiates in animals that are lethargic due to cardiac disease. In addition, a rare side effect-neuroexcitation resulting in pathologic behavioral changes (seizures, mania, muscle fasciculation)-after the administration of morphine or hydromorphone is well-documented in many species. In pigs, however, these drugs have been shown to stimulate an increase in normal activity. In the case presented, we describe a Yorkshire-cross pig which, after myocardial infarction surgery, went from nonresponsive to alert, responsive, and eating within 30 min of an injection of hydromorphone. This pig was not demonstrating any signs associated with pain at this time, suggesting that the positive response was due to neural stimulation. This case report is the first to describe the use of hydromorphone-a potent, pure μ opiate agonist-for its neurostimulatory effect in pigs with experimentally-induced cardiac disease.
Bibliography:1559-6109(20190901)58:5L.601;1-
This article contains supplemental materials online.
ISSN:1559-6109
2769-6677
DOI:10.30802/AALAS-JAALAS-18-000095